Cargando…
Underestimating the Value of an Intervention: The Case for Including Productivity in Value Assessments and Formulary Design
BACKGROUND: Value assessment reports are increasingly being considered in health care coverage decisions. The inputs included and analytic methodologies underlying these reports should include all components of value. OBJECTIVE: To determine whether and how productivity was included in a value asses...
Autores principales: | Karmarkar, Taruja, Graff, Jennifer S., Westrich, Kimberly |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391140/ https://www.ncbi.nlm.nih.gov/pubmed/32347177 http://dx.doi.org/10.18553/jmcp.2020.26.5.652 |
Ejemplares similares
-
Stakeholders find that step therapy should be evidence-based, flexible, and transparent: assessing appropriateness using a consensus approach
por: Karmarkar, Taruja, et al.
Publicado: (2021) -
Payer perceptions and use of value assessment tools in the United States
por: Westrich, Kimberly, et al.
Publicado: (2023) -
Stakeholder perception of pharmaceutical value: A multicriteria decision analysis pilot case study for value assessment in the United States
por: Mendola, Nicholas D, et al.
Publicado: (2022) -
Prescription digital therapeutics: Applying Medicaid experience to value assessment and formulary management
por: Salsabili, Mahsa, et al.
Publicado: (2023) -
Haemoglobin J-Baltimore can be detected by HbA(1c) electropherogram but with underestimated HbA(1c) value
por: Brunel, Valéry, et al.
Publicado: (2016)